Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Scopus by Title (Ref)

1. Polymorphism in interferon λ3/interleukin-28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy

- Khan A.J. , et al.

2. No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B

- Wei L. , et al.

3. Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism

- Ekstrom V. , et al.

4. A new prognostic test of the effectiveness of antiviral therapy for CHC and its comparative assessment with detection of IL28B gene polymorphism

- Khokhlova O.N. , et al.

5. Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: Prevalence, clinical characteristics, viral interactions and host genotypes: A nationwide cross-sectional study

- Yan L. , et al.

6. Interferon Lambda 4 polymorphism predicts sustained viral response in hepatitis C virus patients irrespective of hepatitis C virus genotypes, ethnicity or treatment regimen: Results from a meta-analysis

- Wu Q. , et al.

7. A comprehensive long-term prognosis of chronic hepatitis C patients with antiviral therapy: A meta-analysis of studies from 2008 to 2014

- Wen Y. , et al.

8. Role of interferon gamma and tumor necrosis factor-related apoptosis-inducing ligand receptor 1 single nucleotide polymorphism in natural clearance and treatment response of HCV infection

- Azam S. , et al.

9. The host HLA-A*02 allele is associated with the response to pegylated interferon and ribavirin in patients with chronic hepatitis C virus infection

- Wang M. , et al.